pioglitazone and glimepiride is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Prasco Laboratories. The primary component is Pioglitazone Hydrochloride; Glimepiride.
| Product ID | 66993-821_d682ddb2-aeae-456a-b7ea-3e5c2e9b75bd |
| NDC | 66993-821 |
| Product Type | Human Prescription Drug |
| Proprietary Name | pioglitazone and glimepiride |
| Generic Name | Pioglitazone And Glimepiride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-08-04 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA021925 |
| Labeler Name | Prasco Laboratories |
| Substance Name | PIOGLITAZONE HYDROCHLORIDE; GLIMEPIRIDE |
| Active Ingredient Strength | 30 mg/1; mg/1 |
| Pharm Classes | Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Sulfonylurea [EPC],Sulfonylurea Compounds [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2015-08-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA authorized generic |
| Application Number | NDA021925 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-08-04 |
| Ingredient | Strength |
|---|---|
| PIOGLITAZONE HYDROCHLORIDE | 30 mg/1 |
| SPL SET ID: | ea385b3d-cb4c-4550-97b0-93a86533f6dc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66993-821 | pioglitazone and glimepiride | pioglitazone and glimepiride |
| 66993-822 | pioglitazone and glimepiride | pioglitazone and glimepiride |
| 64764-302 | Duetact | pioglitazone and glimepiride |
| 64764-304 | Duetact | pioglitazone and glimepiride |